• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

充血性心力衰竭患者肾脏对血管紧张素转换酶抑制反应的决定因素。

Determinants of the renal response to ACE inhibition in patients with congestive heart failure.

作者信息

Gottlieb S S, Robinson S, Weir M R, Fisher M L, Krichten C M

机构信息

Department of Medicine, University of Maryland School of Medicine, Baltimore 21201.

出版信息

Am Heart J. 1992 Jul;124(1):131-6. doi: 10.1016/0002-8703(92)90930-t.

DOI:10.1016/0002-8703(92)90930-t
PMID:1615796
Abstract

The objective of the present study was to determine whether pretreatment neurohormonal and renal hemodynamic parameters predict the change in renal function with the administration of quinapril, a new angiotensin-converting enzyme (ACE) inhibitor. Twenty patients with New York Heart Association (NYHA) class III and IV heart failure were evaluated. Following pretreatment determination of renal function and plasma neurohormones, patients were treated daily with 10 mg of quinapril. Measurements of glomerular filtration rate (GFR) and renal plasma flow (RPF) were repeated after 7 weeks to assess changes in function (delta GFR and delta RPF). Mean GFR increased from 49 +/- 6 to 56 +/- 7 ml/min/1.73 m2 (p = 0.10), but decreased in five patients. Mean RPF increased from 235 +/- 23 to 252 +/- 23 ml/min/1.73 m2 (p = 0.08), but decreased in five patients. There was no relation between delta GFR and baseline determinations of GFR, RPF, plasma renin activity, plasma angiotensin II, or serum Na. Only a high filtration fraction (GFR/RPF) predicted a decreased GFR (r = 0.61, p less than 0.005). In contrast, no baseline renal hemodynamic parameter correlated with delta RPF. We conclude that poor renal function does not increase the risk of renal deterioration with quinapril. However, dependence of renal function upon the renin-angiotensin system may be predicted by a high filtration fraction.

摘要

本研究的目的是确定治疗前的神经激素和肾血流动力学参数是否能预测新型血管紧张素转换酶(ACE)抑制剂喹那普利给药后肾功能的变化。对20例纽约心脏协会(NYHA)III级和IV级心力衰竭患者进行了评估。在治疗前测定肾功能和血浆神经激素后,患者每日服用10 mg喹那普利。7周后重复测量肾小球滤过率(GFR)和肾血浆流量(RPF),以评估功能变化(ΔGFR和ΔRPF)。平均GFR从49±6增加至56±7 ml/min/1.73 m²(p = 0.10),但有5例患者GFR下降。平均RPF从235±23增加至252±23 ml/min/1.73 m²(p = 0.08),但有5例患者RPF下降。ΔGFR与GFR、RPF、血浆肾素活性、血浆血管紧张素II或血清钠的基线测定值之间无相关性。只有高滤过分数(GFR/RPF)可预测GFR降低(r = 0.61,p < 0.005)。相比之下,没有基线肾血流动力学参数与ΔRPF相关。我们得出结论,肾功能不佳并不会增加喹那普利导致肾恶化的风险。然而,高滤过分数可能预示着肾功能对肾素-血管紧张素系统的依赖性。

相似文献

1
Determinants of the renal response to ACE inhibition in patients with congestive heart failure.充血性心力衰竭患者肾脏对血管紧张素转换酶抑制反应的决定因素。
Am Heart J. 1992 Jul;124(1):131-6. doi: 10.1016/0002-8703(92)90930-t.
2
Renal morphology and function in dogs after treatment with the angiotensin-converting enzyme inhibitor quinapril.用血管紧张素转换酶抑制剂喹那普利治疗后犬的肾脏形态与功能
J Cardiovasc Pharmacol. 1994 Feb;23(2):275-82. doi: 10.1097/00005344-199402000-00015.
3
Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.人ACE抑制的剂量相关效应:喹那普利用于中度充血性心力衰竭患者。充血性心力衰竭神经激素调节研究组:瑞士洛桑;德国柏林、杜塞尔多夫、慕尼黑
Eur Heart J. 1994 Dec;15 Suppl D:113-22. doi: 10.1093/eurheartj/15.suppl_d.113.
4
Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.激肽和血管紧张素II在大鼠肾血管中血管紧张素转换酶抑制的血管舒张作用中的作用。
J Hypertens. 1997 Jun;15(6):633-41. doi: 10.1097/00004872-199715060-00010.
5
Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.血管紧张素转换酶抑制与血管紧张素II 1型受体拮抗对人体血浆纤溶平衡的比较作用
Hypertension. 1999 Aug;34(2):285-90. doi: 10.1161/01.hyp.34.2.285.
6
Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats.血管紧张素转换酶抑制剂喹那普利对大鼠肾功能的影响。
Arch Int Pharmacodyn Ther. 1993 Jul-Aug;324:87-104.
7
Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.喹那普利在健康志愿者、高血压患者及充血性心力衰竭患者中的临床药理学。
Angiology. 1989 Apr;40(4 Pt 2):360-9. doi: 10.1177/000331978904000405.
8
Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failure.喹那普利对充血性心力衰竭患者局部血流及心功能的评估。
J Clin Pharmacol. 1992 Jan;32(1):70-6. doi: 10.1002/j.1552-4604.1992.tb03791.x.
9
Effects of quinapril hydrochloride in patients with essential hypertension and impaired renal function.盐酸喹那普利对原发性高血压合并肾功能损害患者的疗效
Clin Exp Hypertens. 1997 May;19(4):495-502. doi: 10.3109/10641969709084510.
10
Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.充血性心力衰竭患者首剂服用喹那普利后的血流动力学反应和药代动力学
Br J Clin Pharmacol. 1994 Aug;38(2):117-23. doi: 10.1111/j.1365-2125.1994.tb04334.x.

引用本文的文献

1
Renal effects of adenosine A1-receptor antagonists in congestive heart failure.腺苷A1受体拮抗剂在充血性心力衰竭中的肾脏效应
Drugs. 2001;61(10):1387-93. doi: 10.2165/00003495-200161100-00002.
2
Clinical case studies in heart failure management.心力衰竭管理中的临床病例研究
Br J Clin Pharmacol. 1999 Mar;47(3):239-47. doi: 10.1046/j.1365-2125.1999.00882.x.
3
Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study.盐酸喹那普利对肾功能不全合并高血压患者肾功能的影响:一项撤药研究。
Cardiovasc Drugs Ther. 1994 Apr;8(2):271-5. doi: 10.1007/BF00877336.